Arsalan Seyedi, Fereshteh Yazdanpanah, Stephen J Hunt
{"title":"介入肿瘤学治疗转移性神经内分泌肿瘤的PET-CT研究。","authors":"Arsalan Seyedi, Fereshteh Yazdanpanah, Stephen J Hunt","doi":"10.1016/j.cpet.2025.08.003","DOIUrl":null,"url":null,"abstract":"<p><p>This article highlights the role of PET-computed tomography (CT) imaging in diagnosing and managing metastatic neuroendocrine tumors (mNETs). PET-CT, particularly with Gallium-68-DOTATATE, allows earlier and more precise detection of lesions compared to conventional imaging. It identifies somatostatin receptor-positive tumors, aiding in staging, interventional procedures, and guiding peptide receptor radionuclide therapy. The complementary use of fluorodeoxyglucose-PET for predicting tumor biology and managing aggressive, poorly differentiated tumors, helps provide a comprehensive framework for personalized mNETs management. Finally, PET-CT's role in patient diagnosis, staging, surveillance, and management by the interventional oncologist is outlined in detail.</p>","PeriodicalId":94168,"journal":{"name":"PET clinics","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2025-09-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"PET-CT in the Management of Metastatic Neuroendocrine Tumors by Interventional Oncology.\",\"authors\":\"Arsalan Seyedi, Fereshteh Yazdanpanah, Stephen J Hunt\",\"doi\":\"10.1016/j.cpet.2025.08.003\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>This article highlights the role of PET-computed tomography (CT) imaging in diagnosing and managing metastatic neuroendocrine tumors (mNETs). PET-CT, particularly with Gallium-68-DOTATATE, allows earlier and more precise detection of lesions compared to conventional imaging. It identifies somatostatin receptor-positive tumors, aiding in staging, interventional procedures, and guiding peptide receptor radionuclide therapy. The complementary use of fluorodeoxyglucose-PET for predicting tumor biology and managing aggressive, poorly differentiated tumors, helps provide a comprehensive framework for personalized mNETs management. Finally, PET-CT's role in patient diagnosis, staging, surveillance, and management by the interventional oncologist is outlined in detail.</p>\",\"PeriodicalId\":94168,\"journal\":{\"name\":\"PET clinics\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2025-09-13\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"PET clinics\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1016/j.cpet.2025.08.003\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"PET clinics","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1016/j.cpet.2025.08.003","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
PET-CT in the Management of Metastatic Neuroendocrine Tumors by Interventional Oncology.
This article highlights the role of PET-computed tomography (CT) imaging in diagnosing and managing metastatic neuroendocrine tumors (mNETs). PET-CT, particularly with Gallium-68-DOTATATE, allows earlier and more precise detection of lesions compared to conventional imaging. It identifies somatostatin receptor-positive tumors, aiding in staging, interventional procedures, and guiding peptide receptor radionuclide therapy. The complementary use of fluorodeoxyglucose-PET for predicting tumor biology and managing aggressive, poorly differentiated tumors, helps provide a comprehensive framework for personalized mNETs management. Finally, PET-CT's role in patient diagnosis, staging, surveillance, and management by the interventional oncologist is outlined in detail.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
